$TARS Cashflow Statement | Understand Stock

$TARS

$70.76 +$0.73 (1.04%) Close

$TARS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows From Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Depreciation
Amortization of intangible assets
Amortization/accretion of debt-related costs
Loss on lease termination
Loss on disposal of property and equipment
Amortization of discount on available-for-sale debt securities
Stock-based compensation
Loss on debt extinguishment
Non-cash lease expense
Net amortization/accretion on marketable securities
Realized/unrealized loss (gain) on equity investments
Change in fair value of equity warrants issued by licensee
Unrealized gain from transactions denominated in a foreign currency
Issuance of common stock upon in-license agreement milestone achievement
Changes in operating assets and liabilities:
Accounts receivable, net
Inventory
Other receivables
Prepaid expenses
Other non-current assets
Accounts payable
Accrued payroll and benefits
Other accrued liabilities
Other long-term liabilities

Net cash used in operating activities
Cash Flows From Investing Activities:
Proceeds from sales and maturities of marketable securities
Purchases of marketable securities
Purchases of long-term investments
Intangible asset additions
Purchases of property and equipment
Net cash (used in) provided by investing activities
Cash Flows From Financing Activities:
Proceeds from issuance of common stock
Follow-On Public Offering
2023 ATM Prospectus
Total proceeds from issuance of common stock

Proceeds from issuance of common stock, net of paid issuance costs
Common Stock
2023 ATM Prospectus
Proceeds from issuance of pre-funded warrants, net of paid issuance costs
Proceeds from exercise of stock options
Payments of deferred offering costs
Proceeds from issuance of preferred stock, net of issuance costs
Proceeds from sale of common stock under employee stock purchase plan
Proceeds from long-term debt
Payment of debt issuance costs
Payments for debt extinguishment
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash and cash equivalents
Restricted cash
Supplemental Disclosures From Noncash, Investing and Financing Activities:
Operating lease right-of-use asset obtained in exchange for operating lease liability
Expense of right-of-use asset upon lease termination
Conversion of Preferred Stock into common stock upon initial public offering
Deferred offering costs included in accounts payable and accrued liabilities
Operating lease modification
Interest expense paid in cash
Additions of property and equipment included within accounts payable and other accrued liabilities
Stock issued for in-license agreements included within research and development expense
Offering costs included within accounts payable

Comments